Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

Wall Street is drifting Thursday as gains for fashion brands and cigarette makers help offset drops for Ford Motor and Qualcomm following their latest profit reports. The S&P 500 was up 0.2% in ...

Amgen posted Q4 sales of $9.1 billion, up 11%, surpassing forecasts. EPS beat estimates, and analysts remain optimistic about growth prospects in 2025.

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business ...

US biotech major Amgen =announced that it has reached resolution of its patent infringement litigation related to South Korea ...

In corporate news, ATS Corp (TSX: ATS) reported third-quarter revenue above estimates. ATS shares popped $2.83, or 7.4%, to $41.02.Health-care shares soared 3%, driven by a jump of nine cents, or 6.2% ...

With the overall stock market very overbought, the four highest-yielding Dogs of the Dow look like outstanding ideas now.

S&P 500 E-Mini futures are up +0.05%, andMarch Nasdaq 100 E-Mini futures are down -0.08% this morning as investors awaited a new round of U.S. economic data, remarks from Fe ...

They also usually inherit an "Established Brands" division ... Looking ahead, new biosimilar launches for Amgen's (AMGN) Prolia, and Roche's breast cancer drug Perjeta - both >$4bn per annum ...

Explore our top 10 DJIA stocks picks with expert analysis, market trends, and investment insights to help you make informed ...

Below is Validea's guru fundamental report for AMGEN INC (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Shareholder Yield Investor model based on the published strategy ...